Bone and Chronic Kidney Disease

Abstract

Chronic kidney disease (CKD) induces mineral and bone disorders (CKD-MBD) that affect calcium and phosphate metabolism. This review links pathophysiology, histologic aspects, and radiologic signs. CKD leads to bone lesions, namely renal osteodystrophy, which may combine low or high bone remodeling, impaired mineralization, and bone loss. CKD-MBD also comprises vascular calcifications, which, together with bone disease, lead to a high risk of cardiovascular events and osteoporotic fractures that increase both morbidity and mortality. Osteoporosis assessment is based on screening for classic risk factors and CKD-related factors (disease duration/severity, transplantation history, dialysis vintage). Treatment of mineral disorders may combine serum phosphate lowering drugs, natural vitamin D or its 1-α derivatives, or calcium-sensing receptor agonists. Treatment of osteoporosis is conventional in mild to moderate stages but more complex in severe CKD because evidence about the efficacy and safety of anti-osteoporosis drugs is scant.

Chronic Kidney Disease with Mineral Bone Disorder and Vascular Calcification: An Overview

“…Plain radiographs can identify signs of very severe CKD MBD, such as rugger-jersey vertebral aspect, tumoral calcinosis, brown tumors, or major vascular calcifications [ 83 ]. Lateral thoracic and lumbar radiographs remain the golden standard for diagnosing vertebral fractures, a crucial aspect of ROD [ 84 ].…”